|
[1]
|
MTAP loss: a possible therapeutic approach for glioblastoma
Journal of Translational Medicine,
2022
DOI:10.1186/s12967-022-03823-8
|
|
|
|
|
[2]
|
MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage
Cancer Cell,
2021
DOI:10.1016/j.ccell.2020.12.010
|
|
|
|
|
[3]
|
Cancer Dependencies: PRMT5 and MAT2A in MTAP/p16-Deleted Cancers
Annual Review of Cancer Biology,
2021
DOI:10.1146/annurev-cancerbio-030419-033444
|
|
|
|
|
[4]
|
Data Science for Healthcare
2019
DOI:10.1007/978-3-030-05249-2_13
|
|
|
|
|
[5]
|
Mitochondrial nicotinamide adenine dinucleotide reduced (NADH) oxidation links the tricarboxylic acid (TCA) cycle with methionine metabolism and nuclear DNA methylation
PLOS Biology,
2018
DOI:10.1371/journal.pbio.2005707
|
|
|
|
|
[6]
|
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
Cell Reports,
2016
DOI:10.1016/j.celrep.2016.03.043
|
|
|
|
|
[7]
|
Collateral Lethality: A New Therapeutic Strategy in Oncology
Trends in Cancer,
2015
DOI:10.1016/j.trecan.2015.10.002
|
|
|
|
|
[8]
|
Metabolomic Markers of Altered Nucleotide Metabolism in Early Stage Adenocarcinoma
Cancer Prevention Research,
2015
DOI:10.1158/1940-6207.CAPR-14-0329
|
|
|
|
|
[9]
|
Targeting Metabolic Changes in Cancer: Novel Therapeutic Approaches
Annual Review of Medicine,
2014
DOI:10.1146/annurev-med-092012-112344
|
|
|
|
|
[10]
|
Development of a robust and sensitive LC–MS/MS method for the determination of adenine in plasma of different species and its application to in vivo studies
Journal of Pharmaceutical and Biomedical Analysis,
2011
DOI:10.1016/j.jpba.2011.07.023
|
|
|
|